Consuela A. Albright: Clinical Advocacy in Sickle Cell Disease
Consuela A. Albright, Nurse Practitioner at Cleveland Clinic, shared a post on LinkedIn:
“Advocacy isn’t only the work of patient organizations, it’s also the responsibility of the clinical and research community.
The American Society of Hematology (ASH) is the world’s largest professional society for blood disorder specialists, and sickle cell disease has long been a core focus of its advocacy arm.
ASH advocates for sustained NIH and NHLBI research funding, supports policies that expand access to emerging treatments and curative therapies, and works to build a hematology workforce that reflects the communities most affected by SCD.
As a clinician, I feel this aspect of advocacy most directly: the responsibility to translate bedside experience into policy input and to ensure the people setting research priorities hear from those providing day to day care.
Advocacy from the clinical side doesn’t replace patient led advocacy it should amplify it.”
Stay updated with Hemostasis Today.
-
Sep 5, 2026, 16:28Jon Douglas: Imperial College London Review Maps Key Pathways in Autoimmune Thrombosis
-
Sep 5, 2026, 16:21Kelly Anderson: Bilateral Foot Pain and Purple Toes – Spotting Vascular Complications in Polycythemia Vera
-
Sep 5, 2026, 16:16Hazem Abosheaishaa: Beta-Blocker Selection Matters – Multi-Institutional Cohort Insights on PVT and Survival in Cirrhosis
-
Sep 5, 2026, 16:08Indre Ceponiene: Major Gaps in Secondary Cardiovascular Prevention Across Europe
-
Sep 5, 2026, 16:03W. Alberto Sifuentes Giraldo: Why Obstetric Cases Are Missed Under 2023 ACR/EULAR APS Criteria
-
Sep 5, 2026, 15:58Srikanth Nalla: A Case of Saddle Pulmonary Embolism
-
Sep 5, 2026, 15:55COPD-specific Pulmonary Embolism Diagnostic Strategy – Thrombosis and Haemostasis
-
Sep 5, 2026, 15:41Sam Tsimikas on Lp(a) HORIZON Topline Results – What Missed Endpoints Mean for Cardiovascular Risk
-
Sep 5, 2026, 15:32Stefano Garzon: SELUTION DeNovo HBR – Weren’t HBR Patients Supposed to Bleed More with DES?